Table 1 General and clinical characteristics of patients (N = 114).
From: Time taken to resume activities of daily living after transsphenoidal surgery for pituitary tumors
Variables | n (%)/mean ± SD | Variables | n (%)/mean ± SD |
|---|---|---|---|
Age (years) | 52.4 ± 15.14 | Preexisting TSS/craniotomy | 10 (8.8) |
Sex | Surgical approach I | ||
Male | 57 (50.0) | Transseptal | 91 (79.8) |
Female | 57 (50.0) | Endonasal | 23 (20.2) |
Smoking status | Surgical approach II | ||
Yes | 11 (9.6) | Standard | 89 (78.1) |
No | 103 (90.4) | Extended | 25 (21.9) |
Alcohol consumption | Intraoperative CSF leak | 49 (43.0) | |
Yes | 28 (24.6) | Postoperative problems | 30 (26.3) |
No | 86 (75.4) | CSF leak | 1 (0.9) |
Occupation | Epistaxis | 5 (4.4) | |
Yes | 91(79.8) | Hypopituitarism, transient | 14 (12.3) |
No | 20 (17.6) | Diabetes insipidus, transient | 14 (12.3) |
Unknown | 3 (2.6) | SIADH | 3 (2.6) |
Histological type | Hemorrhage | 3 (2.6) | |
PA, Non-functioning | 81 (71.0) | Third cranial nerve palsy | 2 (1.8) |
PA, Growth hormone-producing | 8 (7.0) | Additional treatment | |
PA, Prolactin-producing | 4 (3.5) | Lumbar drainage | 4 (3.5) |
PA, TSH-producing | 1 (0.9) | Gamma knife radiosurgery | 1 (0.9) |
Craniopharyngioma | 9 (7.9) | Steroid use | 25 (21.9) |
Meningioma | 4 (3.5) | Hospital revisit | 19 (16.7) |
Chordoma | 2 (1.8) | Postoperative hospital stay (days) | 4.6 ± 2.33 |
Othera | 5 (4.4) | Postoperative ICU stay | 24 (21.1) |
